FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|June 3, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of June 3, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 50.9% of total US population has received at least 1 dose
• 41.2% of total US population is fully vaccinated
• 41.2% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Vermont: 56.8%
2. Maine: 55.2%
3. Massachusetts: 54.3%
4. Connecticut: 53.9%
5. Rhode Island: 52.1%
2. Maine: 55.2%
3. Massachusetts: 54.3%
4. Connecticut: 53.9%
5. Rhode Island: 52.1%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 33 321 184 confirmed cases
• 596 332 deaths
• 596 332 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 792 196
2. Texas: 2 957 809
3. Florida: 2 329 867
4. New York: 2 103 768
5. Illinois: 1 383 647
2. Texas: 2 957 809
3. Florida: 2 329 867
4. New York: 2 103 768
5. Illinois: 1 383 647
Deaths: California has the most deaths due to COVID-19 with 63 309 reported fatalities, followed by New York with 53 357, and Texas with 51 631.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 171 828 979 confirmed cases, 3 579 248 deaths, and 2 007 724 895 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
2
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
3
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
4
Lyme Seropositivity Linked to Tick-Borne Co-Exposure in US Laboratory Study
5